The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC
Videos  >  

A Phase III Study of Paclitaxel With Everolimus in Gastric Cancer

Salah-Eddin Al-Batran, MD
Published Online:3:02 PM, Thu January 26, 2017

Salah-Eddin Al-Batran, MD, medical oncologist and Director at the Institute of Clinical Cancer Research, Frankurt, Germany, discusses the findings of a study of paclitaxel with everolimus in gastric cancer.
Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.